IBDEI1Z2 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31492,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,1st tri,fts 2
 ;;^UTILITY(U,$J,358.3,31492,1,4,0)
 ;;=4^O36.0112
 ;;^UTILITY(U,$J,358.3,31492,2)
 ;;=^5016844
 ;;^UTILITY(U,$J,358.3,31493,0)
 ;;=O36.0113^^126^1626^58
 ;;^UTILITY(U,$J,358.3,31493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31493,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,1st tri,fts 3
 ;;^UTILITY(U,$J,358.3,31493,1,4,0)
 ;;=4^O36.0113
 ;;^UTILITY(U,$J,358.3,31493,2)
 ;;=^5016845
 ;;^UTILITY(U,$J,358.3,31494,0)
 ;;=O36.0114^^126^1626^59
 ;;^UTILITY(U,$J,358.3,31494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31494,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,1st tri,fts 4
 ;;^UTILITY(U,$J,358.3,31494,1,4,0)
 ;;=4^O36.0114
 ;;^UTILITY(U,$J,358.3,31494,2)
 ;;=^5016846
 ;;^UTILITY(U,$J,358.3,31495,0)
 ;;=O36.0115^^126^1626^60
 ;;^UTILITY(U,$J,358.3,31495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31495,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,1st tri,fts 5
 ;;^UTILITY(U,$J,358.3,31495,1,4,0)
 ;;=4^O36.0115
 ;;^UTILITY(U,$J,358.3,31495,2)
 ;;=^5016847
 ;;^UTILITY(U,$J,358.3,31496,0)
 ;;=O36.0120^^126^1626^61
 ;;^UTILITY(U,$J,358.3,31496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31496,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,2nd tri,unsp fts
 ;;^UTILITY(U,$J,358.3,31496,1,4,0)
 ;;=4^O36.0120
 ;;^UTILITY(U,$J,358.3,31496,2)
 ;;=^5016849
 ;;^UTILITY(U,$J,358.3,31497,0)
 ;;=O36.0121^^126^1626^62
 ;;^UTILITY(U,$J,358.3,31497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31497,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 1
 ;;^UTILITY(U,$J,358.3,31497,1,4,0)
 ;;=4^O36.0121
 ;;^UTILITY(U,$J,358.3,31497,2)
 ;;=^5016850
 ;;^UTILITY(U,$J,358.3,31498,0)
 ;;=O36.0122^^126^1626^63
 ;;^UTILITY(U,$J,358.3,31498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31498,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 2
 ;;^UTILITY(U,$J,358.3,31498,1,4,0)
 ;;=4^O36.0122
 ;;^UTILITY(U,$J,358.3,31498,2)
 ;;=^5016851
 ;;^UTILITY(U,$J,358.3,31499,0)
 ;;=O36.0123^^126^1626^64
 ;;^UTILITY(U,$J,358.3,31499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31499,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 3
 ;;^UTILITY(U,$J,358.3,31499,1,4,0)
 ;;=4^O36.0123
 ;;^UTILITY(U,$J,358.3,31499,2)
 ;;=^5016852
 ;;^UTILITY(U,$J,358.3,31500,0)
 ;;=O36.0124^^126^1626^65
 ;;^UTILITY(U,$J,358.3,31500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31500,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 4
 ;;^UTILITY(U,$J,358.3,31500,1,4,0)
 ;;=4^O36.0124
 ;;^UTILITY(U,$J,358.3,31500,2)
 ;;=^5016853
 ;;^UTILITY(U,$J,358.3,31501,0)
 ;;=O36.0125^^126^1626^66
 ;;^UTILITY(U,$J,358.3,31501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31501,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 5
 ;;^UTILITY(U,$J,358.3,31501,1,4,0)
 ;;=4^O36.0125
 ;;^UTILITY(U,$J,358.3,31501,2)
 ;;=^5016854
 ;;^UTILITY(U,$J,358.3,31502,0)
 ;;=O36.0130^^126^1626^67
 ;;^UTILITY(U,$J,358.3,31502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31502,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,3rd tri,unsp fts
 ;;^UTILITY(U,$J,358.3,31502,1,4,0)
 ;;=4^O36.0130
 ;;^UTILITY(U,$J,358.3,31502,2)
 ;;=^5016856
 ;;^UTILITY(U,$J,358.3,31503,0)
 ;;=O36.0131^^126^1626^68
 ;;^UTILITY(U,$J,358.3,31503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31503,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,3rd tri,fts 1
